Prof. Rachela Popovtzer is Head of the Laboratory of Nanotheranostics for Personalized Medicine in the Faculty of Engineering, and a member of the Institute of Nanotechnology and Advanced Materials, at Bar Ilan University. She has previously served as Vice Dean and head of the Bioengineering Track in the Faculty of Engineering, and was a visiting Professor at Memorial Sloan Kettering Cancer Center, NY.
Prof. Popovtzer is a winner of numerous international biomedical grants and awards. She has recently been awarded the prestegious European Research Council (ERC) Consolidator grant, to lead research on a novel nanoplatform for delivery of CRISPR to the brain, to treat rare genetic diseases. She has also been awarded 8 million Euro from the European Union's Horizon 2020 program, to scientifically lead a European consortium focused on developing multimodal nanoparticles for non-invasive tracking of therapeutic stem cells for muscle regeneration. Prof. Popovtzer has won additional grants from the NIH, Germany-Israel Foundation (GIF), Israel Science Foundation, Israel Innovation Authority, and the Ministry of Science and Technology.
**Trimodal Nanoparticle Contrast Agent for CT, MRI and SPECT Imaging: Synthesis and Characterization of Radiolabeled Core/Shell Iron Oxide@Gold Nanoparticles**
Nanoparticles have emerged as promising contrast agents for various imaging applications. In our recent paper, we demonstrated synthesis and characterization of a novel hybrid nano-structure, consisting of an iron oxide@gold nanoparticle, labeled with technetium-99m, for trimodal SPECT/CT/MRI imaging. The particles showed efficient capabilities as a CT/MRI imaging agent, and high radiochemical yield, indicating a potential single hybrid material for multimodal SPECT/CT/MRI.
This project received funding from the European Union’s Horizon 2020 Research and Innovation Program, and was published in Chemistry Letters, doi.org/10.1246/cl.180780.
**Please visit our Horizon 2020 project here: https://www.n-track.eu/ ***
SIGINT.bio technology, developed in our lab by our post-doc Dr. Shir Hochwald Liber, has progressed to a new start up company!
This novel technology pioneers gastrointestinal health diagnosis, based on unique bacterial biosensors.
Check out the start-up's new site!:
https://sigintbio.com/
Congratulations to our postdoctoral fellow, Dr. Shir Hochwald-Liber, on being selected for Science Abroad and Israel Innovation Authority's prestigious ScienceMent Leadership Program!
More news
Thanks for your interest!
We always have room for excellent, passionate and motivated students!
Outstanding graduate students with background in Chemistry and/or Engineering and/or Biology are welcome to send an email to rachela.popovtzer@gmail.com
